Bloomage BioTechnology Limited EBIT

Bloomage BioTechnology Limited (688363.SS) currently reports a EBIT of $230M as of September 2026. That compares with $11M in the prior-year period — up 1878.8% year over year. That is below the sector sector average of $2.6T. Use the charts on this page to explore Bloomage BioTechnology Limited's EBIT history and peer comparisons.

Bloomage BioTechnology Limited's EBIT increased from $11M to $230M — a 1878.8% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bloomage BioTechnology Limited's EBIT of $230M is lower than the its sector sector average of $2.6T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Bloomage BioTechnology Limited reported $230M in EBIT as of September 2026. That compares with $11M in the prior-year period — up 1878.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $230M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.6T. From there, open related valuation or income-statement pages for Bloomage BioTechnology Limited, and consider following 688363.SS for alerts when major investors trade the stock.